Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori
- PMID: 9083755
- DOI: 10.1007/s004310050578
Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori
Abstract
There is as yet no consensus about the need for treatment of Helicobacter pylori infections, except for H. pylori-associated peptic ulcer. We present a 3-year-old boy with a 3-month history of oedema and hypoproteinaemia associated with hypertrophic gastropathy. Abdominal scintigram using intravenous 99mTc-labelled human serum albumin scintigraphy and direct measurement of protein in gastric juice proved that serum proteins were massively secreted in the stomach. Histological findings of mucosal inflammation were observed and H. pylori was isolated from the gastric mucosa. The protein loss promptly stopped within 2 weeks of the beginning of eradication therapy.
Conclusion: Protein-losing hypertrophic gastropathy may be induced by Helicobacter pylori-associated gastritis and should therefore be carefully evaluated by histological and bacteriological examination to provide a basis for eradication of H. pylori.
Similar articles
-
Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.J Gastroenterol Hepatol. 1998 Jul;13(7):725-31. doi: 10.1111/j.1440-1746.1998.tb00721.x. J Gastroenterol Hepatol. 1998. PMID: 9715425 Clinical Trial.
-
Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.J Gastroenterol Hepatol. 2000 Oct;15(10):1113-9. doi: 10.1046/j.1440-1746.2000.02317.x. J Gastroenterol Hepatol. 2000. PMID: 11106089
-
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x. Am J Gastroenterol. 1998. PMID: 9576452 Clinical Trial.
-
[Helicobacter pylori induced gastritis: recent topics on eradication therapy].Nihon Shokakibyo Gakkai Zasshi. 2002 Nov;99(11):1312-6. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12462049 Review. Japanese. No abstract available.
-
Gastrointestinal: Rapid emergence of double-expressor lymphoma after Helicobacter pylori eradication therapy.J Gastroenterol Hepatol. 2021 Feb;36(2):299. doi: 10.1111/jgh.15162. Epub 2020 Jul 9. J Gastroenterol Hepatol. 2021. PMID: 32648301 Review. No abstract available.
Cited by
-
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.Pediatr Int. 2020 Dec;62(12):1315-1331. doi: 10.1111/ped.14388. Pediatr Int. 2020. PMID: 32657507 Free PMC article.
-
A case of cytomegalovirus-negative Ménétrier's disease with eosinophilia in a child.Korean J Pediatr. 2012 Aug;55(8):293-6. doi: 10.3345/kjp.2012.55.8.293. Epub 2012 Aug 23. Korean J Pediatr. 2012. PMID: 22977442 Free PMC article.
-
Helicobacter pylori isolated from a patient with Ménétrier's disease increases hepatocyte growth factor mRNA expression in gastric fibroblasts: comparison with Helicobacter pylori isolated from other gastric diseases.Dig Dis Sci. 2008 Jul;53(7):1785-91. doi: 10.1007/s10620-007-0070-4. Epub 2007 Nov 8. Dig Dis Sci. 2008. PMID: 17990109
-
Protein-losing gastroenteropathy associated with primary Sjögren's syndrome: a characteristic oriental variant.Rheumatol Int. 2009 May;29(7):817-20. doi: 10.1007/s00296-008-0794-2. Epub 2008 Nov 29. Rheumatol Int. 2009. PMID: 19043715
-
Cytomegalovirus and Helicobacter pylori co-infection in a child with Ménétrier disease.Eur J Pediatr. 2007 Jan;166(1):63-5. doi: 10.1007/s00431-006-0183-3. Epub 2006 Jul 21. Eur J Pediatr. 2007. PMID: 16858581
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical